http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1692118-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce36bb72d8f7742915ae8ea0ebe2da0e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-22
filingDate 2004-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81521f96303e8ba6415e62b3e77d53b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b67bff94023d8ccb3014b8fadd89dfcf
publicationDate 2007-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1692118-B1
titleOfInvention A process for the resolution of nefopam
abstract A process for increasing the optical purity of a mixture of enantiomers of nefopam uses a substantially single enantiomer of a O,O-diaroyltartaric acid as a resolving agent, via a bisnefopam salt of the acid. This salt is new.
priorityDate 2003-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226574698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226575828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127646011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12275548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129825399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129825395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226452827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129825398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129126420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1550213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226784614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID184147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226651176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86498

Total number of triples: 46.